Processa Pharmaceuticals
PCSA
PCSA
18 hedge funds and large institutions have $3.22M invested in Processa Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Wells Fargo
San Francisco,
California
|
$9K |
2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$9K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$3K |